Expanding Horizon of Cervical Cancer Screening by Involving Antenatal Patients

Pahwa, Dr Sangeeta

doi:10.18535/jmscr/v4i12.80

jmscr

2016

DOI: 10.18535/jmscr/v4i12.80

|View full text |Cite

Expanding Horizon of Cervical Cancer Screening by Involving Antenatal Patients

Dr Sangeeta Pahwa¹

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Evaluation of cervical cancer screening during pregnancy in India: Human papillomavirus testing can change the paradigm

SUDHAKARAN,

BHATLA,

MATHUR

et al. 2023

NMJI

View full text Add to dashboard Cite

Background The World Health Organization’s call for elimination of cervical cancer envisages 70% screening coverage of women aged 35 and 45 years by an effective test. In India, this target seems unrealistic as awareness and access to cancer prevention services are poor. However, the institutional delivery rate is now >80%. We evaluated the acceptability and feasibility of human papillomavirus (HPV) testing and its role in screening during pregnancy. Methods This observational study recruited 275 pregnant women aged >25 years between 12 and 34 weeks of gestation for screening by cytology and HPV testing. Colposcopy was advised if either test was positive. Acceptability and feasibility were assessed by a questionnaire. Results Cytology and HPV reports were available for 269 subjects. The median age was 28 years and median parity was two. Only 98 (36.4%) had heard about carcinoma cervix. Awareness improved with education (p<0.001). On cytology, only 4 (1.5%) were abnormal (atypical squamous cells of undetermined significance 3; low-grade squamous intraepithelial lesion 1). The prevalence of high-risk HPV infection was 8.2% (22/269). On colposcopy, all had the Swede score <5. No high-grade cervical intraepithelial neoplasia or carcinoma was detected. Pre-procedure, 183 (68.0%) subjects expressed apprehension, post-procedure 114 (42.4%) of them had realized that their apprehensions were unfounded. Women found screening to be more uncomfortable after 28 weeks of gestation (n=26/68; 38.2%; p<0.001). Physicians found the cervix more difficult to visualize after 20 weeks of gestation (p<0.001). Conclusions HPV screening at 16–20 weeks of pregnancy is acceptable, feasible, and can greatly improve screening coverage in resource-limited settings. Pregnancy is a good opportunity to improve awareness of the screening programmes.

show abstract

Evaluation of cervical cancer screening during pregnancy in India: Human papillomavirus testing can change the paradigm

SUDHAKARAN,

BHATLA,

MATHUR

et al. 2023

NMJI

View full text Add to dashboard Cite

show abstract

“Prevalence of Abnormal Cervical Cytology in Antenatal Women by Liquid Based Cytology in a Tertiary Care Hospital in North India”

Ankita¹,

Zutshi²,

Singh

2021

ijsr

View full text Add to dashboard Cite

Background: This study aimed to know the prevalence of abnormal cervical cytology in pregnant women by liquid-based cytology (LBC). Materials and Methods : Cross sectional study done at a tertiary care hospital in between August 2017 to January 2019.Six hundred pregnant women attending the OPD at their rst visit were enrolled and after taking consent, history and clinical examination , subjected to cervical cancer screening by LBC. Result: Out of 600 samples, 10 samples (1.67%) were unsatisfactory for evaluation due to low cellularity. Among 590 samples, only 2 reported as LSIL(Low grade squamous intraepithelial lesion) and 588 reported as NILM (Negative for intraepithelial lesion or malignancy). Inammation of varying degree, mild, moderate and dense was reported in 58.65%, 24.92% and 16.44% respectively. Infection was reported in 3.73% and Candida. Discussion: prevalence of abnormal cervical cytology among pregnant women in region was low but screening for cancer cervix should be done for all pregnant women, adverse pregnancy outcomes like premature rupture of membranes, preterm birth and low birth weight.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Expanding Horizon of Cervical Cancer Screening by Involving Antenatal Patients

Cited by 2 publications

References 10 publications

Evaluation of cervical cancer screening during pregnancy in India: Human papillomavirus testing can change the paradigm

Evaluation of cervical cancer screening during pregnancy in India: Human papillomavirus testing can change the paradigm

“Prevalence of Abnormal Cervical Cytology in Antenatal Women by Liquid Based Cytology in a Tertiary Care Hospital in North India”

Contact Info

Product

Resources

About